Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Robert Koremans
Age : 59
Country of residence : Unknown
Linked companies : Recordati Industria Chimica e Farmaceutica S.p.A.

Summary 
Robert Koremans is a businessperson who has been at the head of 6 different companies. Currently, he occupies the position of Chief Executive Officer at Recordati SpA.

In his past career Dr. Koremans held the position of Chief Executive Officer at Zentiva Group AS, Chief Executive Officer for Esperite NV and Chief Executive Officer at Cryo-Save CZ sro (a subsidiary of Esperite NV), President & CEO-Global Specialty Medicines at Teva Pharmaceutical Industries Ltd. and President & Chief Executive Officer for Teva Pharmaceuticals Europe BV (a subsidiary of Teva Pharmaceutical Industries Ltd.), Senior VP-Generics, Strategy & Development at Sanofi, Vice President-Europe, Middle East & Africa at Serono Corp. and Chairman-Executive Board & Chief Executive Officer at Nutreco NV.

He received a doctorate from Erasmus University Rotterdam.




Current positions of Robert Koremans 
Robert Koremans : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
Robert Koremans : Connections 


Latest news about Robert Koremans 
05/10Recordati Industria Chimica Seeks M&A
CI
05/10TRANSCRIPT : Recordati Industria Chimica e Farmaceutica S.p.A., Q1 2022 Earnings Call, May 10, 2022
CI
02/24TRANSCRIPT : Recordati Industria Chimica e Farmaceutica S.p.A., 2021 Earnings Call, Feb 24, 2022
CI
2021Recordati's CEO Takes Over Chair Role; New CEO Appointed
MT
2017TRANSCRIPT : Teva Pharmaceutical Industries Limited, Q3 2017 Earnings Call, Nov 02, 2017
CI
2017TRANSCRIPT : Teva Pharmaceutical Industries Limited, Q1 2017 Earnings Call, May 11, 2017
CI
2017TRANSCRIPT : Teva Pharmaceutical Industries Limited, Q4 2016 Earnings Call, Feb 13, 2017
CI
More news